Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
- Status
- COMPLETED
- Phase
- N/A
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Skin Care Behaviors Among Melanoma Survivors and Their Families
- Status
- COMPLETED
- Phase
- NA
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
- Status
- TERMINATED
- Phase
- NA
Safety Study of AMG 228 to Treat Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Melanoma Perception and Health Literacy in People of Color
- Status
- COMPLETED
- Phase
- NA
Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
- Status
- COMPLETED
- Phase
- PHASE1
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)
- Status
- COMPLETED
- Phase
- NA
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE3
FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)
- Status
- COMPLETED
- Phase
- N/A